- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT07813078
Anti-Gravity Treadmill Gait Training for Knee Osteoarthritis
4 de septiembre de 2026 actualizado por: Piotr Pastyrzak, University of Rzeszow
Evaluation of the Effectiveness of Traditional Physiotherapy Supported by Gait Re-education Using the R-Force Anti-Gravity Treadmill in Patients With Knee Osteoarthritis - Randomized Clinical Trial
Purpose: The aim of the study will be to evaluate the effectiveness of traditional physiotherapy supported by gait re-education using the R-Force bodyweight-supported treadmill in improving gait parameters, range of motion, knee joint function, quality of life, and body composition in patients with knee osteoarthritis.
The study will be conducted in the form of a prospective, randomized clinical trial with participants divided into two therapeutic groups: a control group and an experimental group.
The therapeutic program will last 4 weeks and will be implemented 3 times a week.
Changes in gait parameters, range of motion, knee joint function, quality of life, and body composition will be evaluated.Material:
The study will include patients ≥ 40 years of age with knee osteoarthritis (Kellgren-Lawrence grade 2 or 3), confirmed radiologically, reporting pain lasting ≥ 3 months.
Participants (n = 80) will be randomly assigned to the control group (conventional physiotherapy) or the experimental group (conventional physiotherapy + training on the R-Force treadmill).Methods: Participants will be assessed at three time points: before the intervention (baseline), after completing the 4-week therapeutic program (postintervention), and after 8 weeks (follow-up).
The methods used will include: analysis of gait parameters on the R-Force treadmill, 6-Minute Walk Test (6MWT), Timed Up and Go (TUG) test, measurements of knee joint range of motion using a goniometer, thigh and lower leg circumference measurements, body composition analysis using the BIA method, subjective pain assessment using the Visual Analog Scale (VAS) and Laitinen scale, pressure pain threshold assessment using a digital algometer, functional assessment using the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) and Knee Injury and Osteoarthritis Outcome Score (KOOS) questionnaires, quality of life assessment (WHOQOL-BREF), Hospital Anxiety and Depression Scale (HADS), as well as assessment of periarticular structures using ultrasound.
Descripción general del estudio
Estado
Reclutamiento
Condiciones
Intervención / Tratamiento
Tipo de estudio
Intervencionista
Inscripción (Estimado)
80
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Estudio Contacto
- Nombre: Piotr Pastyrzak, MSc
- Número de teléfono: 531-078-080
- Correo electrónico: piotr.pastyrzak@gmail.com,
Ubicaciones de estudio
-
-
Podkarpackie Voivodeship
-
Sanok, Podkarpackie Voivodeship, Polonia, 35-800
- Reclutamiento
- Centrum Rehabilitacji niemowląt, dzieci i dorosłych SensoReh Karolina Banaś - Pastyrzak,
-
Contacto:
- Piotr Pastyrzak, MSc
- Número de teléfono: 531-078-080
- Correo electrónico: piotr.pastyrzak@gmail.com
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
No
Descripción
Inclusion Criteria:
- Radiologically confirmed knee osteoarthritis (grade 2 or 3 according to the Kellgren-Lawrence classification).
- General health and functional status allowing participation in the physical therapy program (based on clinical assessment).
- Knee joint pain persisting for at least 3 months, with an intensity of >= 4 on the Visual Analog Scale (VAS).
- Age between 40 and 70 years.
- Ability to ambulate independently without any orthopedic assistive devices.
- Voluntary written informed consent to participate in the study.
- No medical contraindications to physical exercise.
Exclusion Criteria:
- Knee osteoarthritis grade 4 according to the Kellgren-Lawrence classification or lack of radiological changes (grade 0-1).
- History of total or partial knee arthroplasty (joint replacement).
- Contraindications to body composition analysis (e.g., implanted pacemaker, electronic implants, epilepsy).
- Knee joint instability (e.g., ligamentous injury).
- Acute joint inflammation.
- Neuropathies, myopathies, or other neurological conditions affecting gait.
- Active neoplastic diseases (cancer) or advanced cardiovascular diseases.
- Participation in other clinical trials within the last 6 months.
- Participation in another physical therapy or rehabilitation program within the last 6 months.
- Planned intra-articular injections or injections received in the affected knee joint within the last 3 months.
- Regular use of analgesic or anti-inflammatory drugs (NSAIDs, corticosteroids) at doses that could affect the assessment of pain and function.
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Tratamiento
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Experimental Group
Patients in this group will receive a comprehensive 4-week therapeutic program, 3 times a week.
The intervention combines conventional physiotherapy with gait re-education and training on the R-Force bodyweight- supported anti-gravity treadmill.
Each therapy session will last approximately 90 minutes.
|
A standard program consisting of targeted physical exercises, range of motion improvements, and strength conditioning for patients with knee osteoarthritis.
Traditional physiotherapy will include isometric exercises, strengthening, stretching, balance exercises (with elements of proprioception training), active non-weight-bearing exercises, functional exercises, gait exercises, as well as breathing and relaxation exercises.
Gait re-education and body-weight-supported treadmill training using the R-Force anti-gravity treadmill to reduce joint loading during exercise.
|
|
Comparador activo: Control Group
Patients in this group will undergo a standard 4- week conventional physiotherapy program, 3 times a week.
Each therapy session will last approximately 90 minutes.
|
A standard program consisting of targeted physical exercises, range of motion improvements, and strength conditioning for patients with knee osteoarthritis.
Traditional physiotherapy will include isometric exercises, strengthening, stretching, balance exercises (with elements of proprioception training), active non-weight-bearing exercises, functional exercises, gait exercises, as well as breathing and relaxation exercises.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Knee Injury and Osteoarthritis Outcome Score (KOOS)
Periodo de tiempo: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in knee joint function and symptoms using the KOOS questionnaire.
The questionnaire assesses 5 subscales: Pain, Symptoms, Activities of Daily Living, Sport and Recreation Function, and Knee-related Quality of Life.
Scores range from 0 to 100, where 100 indicates no symptoms and 0 indicates extreme symptoms.
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Gait Parameters - Stride Length
Periodo de tiempo: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in mean stride length (measured in centimeters) during treadmill walking, evaluated using the built-in spatio-temporal analysis system of the R-Force treadmill.
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Subjective Pain Assessment using Visual Analog Scale (VAS)
Periodo de tiempo: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in self-reported knee pain intensity during movement using a 100 mm Visual Analog Scale, where 0 mm represents "no pain" and 100 mm represents "worst imaginable pain"
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Functional Walking Capacity via 6-Minute Walk Test (6MWT)
Periodo de tiempo: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in the maximum distance (measured in meters) that a participant can walk quickly on a flat, hard surface in a period of 6 minutes.
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Mobility and Balance via Timed Up and Go (TUG) Test
Periodo de tiempo: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in the time (measured in seconds) taken by a participant to rise from a chair, walk 3 meters, turn around, walk back to the chair, and sit down.
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Knee Joint Range of Motion (ROM)
Periodo de tiempo: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in active and passive knee joint flexion and extension angles, measured in degrees using a standard universal goniometer
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Pressure Pain Threshold (PPT)
Periodo de tiempo: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in pressure pain threshold at standardized periarticular sites around the knee, measured in kilograms per square centimeter (kg/cm2) using a digital pressure algometer.
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
|
Ultrasound Assessment of Periarticular Structures
Periodo de tiempo: Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Change from baseline in structural features of periarticular tissues (such as joint effusion volume, synovial thickness, or tendon presentation) evaluated qualitatively and quantitatively via knee ultrasonography
|
Baseline (before intervention), 4 weeks (immediately post-intervention), and 8 weeks (follow-up)
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio (Actual)
5 de enero de 2026
Finalización primaria (Estimado)
31 de diciembre de 2026
Finalización del estudio (Estimado)
30 de junio de 2027
Fechas de registro del estudio
Enviado por primera vez
4 de septiembre de 2026
Primero enviado que cumplió con los criterios de control de calidad
4 de septiembre de 2026
Publicado por primera vez (Actual)
10 de septiembre de 2026
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
10 de septiembre de 2026
Última actualización enviada que cumplió con los criterios de control de calidad
4 de septiembre de 2026
Última verificación
1 de mayo de 2026
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- Resolution No. 4/12/2025/W
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
NO
Descripción del plan IPD
Individual participant data will not be made publicly available due to institutional data protection regulations, patient privacy restrictions, and the scope of the doctoral research project.
Aggregate data and study findings will be disseminated exclusively through peer-reviewed scientific publications and conference presentations
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
No
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
No
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .